[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100594116":3},{"organization":4,"armGroups":7,"interventions":10,"overallOfficials":12,"centralContacts":20,"locations":30,"responsibleParty":42,"collaborators":10,"id":44,"slug":45,"hasResults":46,"nctId":47,"briefTitle":48,"officialTitle":49,"acronym":10,"eligibilityCriteria":50,"healthyVolunteers":46,"sex":51,"minAge":10,"maxAge":10,"enrollmentInfo":52,"targetDuration":10,"studyType":55,"phases":10,"briefSummary":56,"conditions":57,"keywords":63,"overallStatus":83,"whyStopped":10,"lastUpdateSubmitDate":84,"lastUpdatePostDateStruct":85,"startDateStruct":88,"completionDateStruct":90,"leadSponsor":92,"locationsCount":93},{"fullName":5,"class":6},"Abu Dhabi Health Services Company","OTHER_GOV",[8],{"label":9,"type":10,"description":11,"interventionNames":10},"Infants, adults, elderly, and high-risk patients with confirmed RSV infection (2018-2024).",null,"This retrospective study includes patients of all ages with confirmed Respiratory Syncytial Virus (RSV) infection from January 2018 to December 2024, categorized into four cohorts: (1) Infants and young children, including those with risk factors such as prematurity, low birth weight, and chronic lung or heart disease; (2) Adults aged 18-64 years with or without comorbidities; (3) Elderly adults aged 65 and older, with focus on severe outcomes and mortality; and (4) High-risk individuals across all age groups with underlying conditions such as asthma, COPD, diabetes, immunosuppression, Down syndrome, or cystic fibrosis. No interventions are administered; the study analyzes existing data to assess RSV burden, ICU admissions, long-term health impacts, and associated healthcare costs.",[13,17],{"name":14,"affiliation":15,"role":16},"Salah Eldin Hussein, MD","Abu Dhabi Health Services Company-SEHA","STUDY_DIRECTOR",{"name":18,"affiliation":15,"role":19},"Nawal Alkaabi, MD","PRINCIPAL_INVESTIGATOR",[21,26],{"name":22,"role":23,"phone":24,"phoneExt":10,"email":25},"Lina Khairy, MD","CONTACT","+971589111897","o-lkhayri@seha.ae",{"name":27,"role":23,"phone":28,"phoneExt":10,"email":29},"Alina Naeem, MBBS, MS","+971566089799","alina.naeem@purehealth.ae",[31],{"facility":32,"status":10,"city":33,"state":10,"zip":10,"country":34,"countryCode":35,"cosmosGeoPoint":36,"geoPoint":41,"contacts":10},"Sheikh Khalifa Medical City (Abu Dhabi Health Research Centre), SEHA","Abu Dhabi","United Arab Emirates","AE",{"type":37,"coordinates":38},"Point",[39,40],54.39696,24.45118,{"lat":40,"lon":39},{"type":43,"investigatorFullName":10,"investigatorTitle":10,"investigatorAffiliation":10,"oldNameTitle":10,"oldOrganization":10},"SPONSOR","100594116","assessing-the-burden-of-respiratory-syncytial-virus-rsv-100594116",false,"NCT07015255","Assessing the Burden of Respiratory Syncytial Virus (RSV)","Assessing the Burden of Respiratory Syncytial Virus (RSV): the Assessment of the Burden of Respiratory Syncytial Virus (RSV) Across Different Age Groups and Risk Factors","Inclusion Criteria:\n\n* Patients of all ages with a confirmed diagnosis of RSV infection\n* Patients admitted to a SEHA hospital or healthcare facility between January 2018 and December 2024\n* Patients with documented data in the SEHA electronic medical record (EMR) system\n\nExclusion Criteria:\n\n* Patients with suspected RSV infection that is not laboratory-confirmed\n* Patients without sufficient data in the SEHA EMR system","ALL",{"count":53,"type":54},1500,"ESTIMATED","OBSERVATIONAL","This study examines the impact of Respiratory Syncytial Virus (RSV) on people of all ages, from infants to the elderly. It uses hospital records collected between January 2018 and December 2024 to understand:\n\n* How often does RSV occur\n* Who is most at risk\n* The long-term and financial effects of RSV",[58,59,60,61,62],"Respiratory Syncytial Virus (RSV) Infection","Acute Lower Respiratory Tract Infections","Bronchiolitis","Pneumonia","Chronic Respiratory Conditions",[64,65,66,67,68,69,70,71,72,73,74,75,76,77,78,79,60,61,80,81,82],"Respiratory Syncytial Virus","RSV","RSV Infection","RSV in Infants","RSV in Adults","RSV Hospitalization","RSV Epidemiology","RSV Burden","RSV Risk Factors","Retrospective Study","Observational Study","ICU Admissions","RSV Mortality","RSV Cost Analysis","RSV Complications","Asthma and RSV","Recurrent Wheezing","RSV Surveillance","RSV-Related Comorbidities","NOT_YET_RECRUITING","2025-06-17",{"date":86,"type":87},"2025-06-19","ACTUAL",{"date":89,"type":54},"2025-06",{"date":91,"type":54},"2026-06",{"name":5,"class":6},1]